Cargando…

Mitochondrion-associated protein peroxiredoxin 3 promotes benign prostatic hyperplasia through autophagy suppression and pyroptosis activation

Benign prostatic hyperplasia (BPH) is one of the most common diseases in the senior men and age plays an important role in the initiation and development of BPH. Mammalian cells primarily use the autophagy-lysosome system to degrade misfolded/aggregated proteins and dysfunctional organelles such as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Min-Yao, Han, Zhao-Dong, Li, Wenjiao, Yue, Fei, Ye, Jianheng, Li, Bowei, Cai, Zhiduan, Lu, Jian-Ming, Dong, Weimin, Jiang, Xianhan, Zhong, Weide, He, Huichan, Liu, Leyuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5655198/ https://www.ncbi.nlm.nih.gov/pubmed/29113303 http://dx.doi.org/10.18632/oncotarget.17927

Ejemplares similares

Mitochondrion-associated protein LRPPRC suppresses the initiation of basal levels of autophagy via enhancing Bcl-2 stability
por: Zou, Jing, et al.
Publicado: (2013)

Autophagy Inhibitor LRPPRC Suppresses Mitophagy through Interaction with Mitophagy Initiator Parkin
por: Zou, Jing, et al.
Publicado: (2014)

Increased expression of immediate early response gene 3 protein promotes aggressive progression and predicts poor prognosis in human bladder cancer
por: Ye, Jianheng, et al.
Publicado: (2018)

Suppressor of hepatocellular carcinoma RASSF1A activates autophagy initiation and maturation
por: Li, Wenjiao, et al.
Publicado: (2018)

Measurement of autophagy flux in benign prostatic hyperplasia in vitro
por: Oh, Sung-hee, et al.
Publicado: (2020)

Defects in MAP1S-mediated autophagy turnover of fibronectin cause renal fibrosis
por: Xu, Guibin, et al.
Publicado: (2016)

Roles of autophagy in androgen-induced benign prostatic hyperplasia in castrated rats
por: Liu, Rong-Fu, et al.
Publicado: (2018)

Fast clearance of lipid droplets through MAP1S-activated autophagy suppresses clear cell renal cell carcinomas and promotes patient survival
por: Xu, Guibin, et al.
Publicado: (2015)

Characterization of a Pyroptosis-Related Signature for Prognosis Prediction and Immune Microenvironment Infiltration in Prostate Cancer
por: Zhang, Guian, et al.
Publicado: (2022)

Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer
por: Ye, Jianheng, et al.
Publicado: (2023)

Peroxiredoxin 1 regulates crosstalk between pyroptosis and autophagy in oral squamous cell carcinoma leading to a potential pro-survival
por: Ye, Meilin, et al.
Publicado: (2023)

Correlation between Cholinergic Innervation, Autophagy, and Etiopathology of Benign Prostatic Hyperplasia
por: Cai, Jian-Liang, et al.
Publicado: (2017)

Autophagy Activated by Peroxiredoxin of Entamoeba histolytica
por: Li, Xia, et al.
Publicado: (2020)

The prognostic roles of CYP19A1 expression in bladder cancer patients of different genders
por: Cai, Shanghua, et al.
Publicado: (2021)

Benign Prostatic Hyperplasia
Publicado: (2015)

Qianliening capsule inhibits benign prostatic hyperplasia angiogenesis via the HIF-1α signaling pathway
por: LIN, JIUMAO, et al.
Publicado: (2014)

Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer
por: Zhang, Yanqiong, et al.
Publicado: (2018)

Autophagy: a stumbling block of androgen inhibition to treat benign prostatic hyperplasia or prostate cancer
por: Zhang, Li, et al.
Publicado: (2016)

PCSK9 Promotes Hypoxia-Induced EC Pyroptosis by Regulating Smac Mitochondrion-Cytoplasm Translocation in Critical Limb Ischemia
por: Zhang, Meixin, et al.
Publicado: (2023)

Qianliening capsule treats benign prostatic hyperplasia via suppression of the EGF/STAT3 signaling pathway
por: LIN, JIUMAO, et al.
Publicado: (2013)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Peroxiredoxin 3 Inhibits Acetaminophen-Induced Liver Pyroptosis Through the Regulation of Mitochondrial ROS
por: Wang, Yue, et al.
Publicado: (2021)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

The Emerging Role of Cell Adhesion Molecules on Benign Prostatic Hyperplasia
por: Liu, Jiang, et al.
Publicado: (2023)

Biocompatibility and efficacy of prostatic urethral lift in benign prostate hyperplasia: an in vivo and in vitro study
por: Xia, Yuqi, et al.
Publicado: (2023)

Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer
por: Feng, Yuanfa, et al.
Publicado: (2023)

ALDH2 attenuates myocardial pyroptosis through breaking down Mitochondrion-NLRP3 inflammasome pathway in septic shock
por: Zhang, Ying, et al.
Publicado: (2023)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Sodium butyrate treatment and fecal microbiota transplantation provide relief from ulcerative colitis-induced prostate enlargement
por: Dong, Weimin, et al.
Publicado: (2022)

Expression of Heat Shock Protein 27 in Benign Prostatic Hyperplasia with Chronic Inflammation
por: Jiang, Yuqing, et al.
Publicado: (2015)

The Symptoms of Benign Prostatic Hyperplasia Patients with Stromal-Dominated Hyperplasia Nodules May Be Associated with Prostate Fibrosis
por: Cao, Ying, et al.
Publicado: (2023)

Combination of transurethral resection of the prostate and flexible and rigid ureteroscopy for benign prostatic hyperplasia and ureteral calculus
por: He, Kunlun, et al.
Publicado: (2021)

Risk factors for bladder calculi in patients with benign prostatic hyperplasia
por: Huang, Wei, et al.
Publicado: (2017)

Is myelin a mitochondrion?
por: Harris, Julia J, et al.
Publicado: (2013)

Of mitochondrion and COVID-19
por: Alfarouk, Khalid Omer, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8tq0p19fhcud8su1v3rre4b64i